Epoetin alfa Injection and Inotuzumab ozogamicin Intravenous
Determining the interaction of Epoetin alfa Injection and Inotuzumab ozogamicin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: epoetin alfa
Brand name: Epogen, Procrit, Retacrit
Synonyms: Epoetin alfa, Epoetin Alfa
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab ozogamicin, Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Epoetin alfa Injection-Inova
- Epoetin alfa Injection-Inova 4/1 topical
- Epoetin alfa Injection-Inova 8/2 topical
- Epoetin alfa Injection-Inova ACT
- Epoetin alfa Injection-Inrebic
- Epoetin alfa Injection-Inspra
- Inotuzumab ozogamicin Intravenous-Epoetin Alfa Vials
- Inotuzumab ozogamicin Intravenous-Epoetin Alfa-epbx
- Inotuzumab ozogamicin Intravenous-Epoetin alfa-epbx Injection
- Inotuzumab ozogamicin Intravenous-Epoetin beta and methoxy polyethylene glycol
- Inotuzumab ozogamicin Intravenous-Epogen
- Inotuzumab ozogamicin Intravenous-Epoprostenol